Pharmacyte Biotech Inc (PMCB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 01-2017 | 10-2016 | 07-2016 | 04-2016 | 01-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,464 | 1,552 | 2,340 | 1,921 | 2,864 |
| TOTAL | $2,486 | $1,603 | $2,394 | $2,031 | $2,872 |
| Non-Current Assets | |||||
| Investments And Advances | 1,572 | 1,572 | 1,572 | 1,572 | 1,572 |
| Intangibles | 3,549 | 3,549 | 3,549 | 3,549 | 3,549 |
| Other Non-Current Assets | 7 | 7 | 8 | 8 | 8 |
| TOTAL | $5,129 | $5,129 | $5,130 | $5,130 | $5,130 |
| Total Assets | $7,615 | $6,732 | $7,524 | $7,160 | $8,002 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 150 | 300 |
| Accounts payable and accrued liabilities | 435 | 301 | 312 | 336 | 697 |
| Accrued Expenses | 143 | 148 | 145 | 152 | 68 |
| TOTAL | $578 | $449 | $457 | $638 | $1,065 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $578 | $449 | $457 | $638 | $1,065 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 613 | 595 | 594 | 594 | 540 |
| Common Shares | 87 | 85 | 85 | 78 | 77 |
| Retained earnings | -87,980 | -86,698 | -85,724 | -84,692 | -83,570 |
| Other shareholders' equity | 2 | 2 | 1 | 1 | 2 |
| TOTAL | $7,037 | $6,283 | $7,067 | $6,523 | $6,936 |
| Total Liabilities And Equity | $7,615 | $6,732 | $7,524 | $7,160 | $8,002 |